BioCorRx (BICX) Non-Current Deffered Revenue (2013 - 2024)
BioCorRx (BICX) posted Non-Current Deffered Revenue of $4045.0 for Q1 2024, little changed sequentially from $4045.0 in Q4 2023, and little changed YoY from $4045.0 in Q2 2023.
Powered by 
Analysis
BioCorRx (BICX) Non-Current Deffered Revenue (2013 - 2024) Analysis & Trends
BioCorRx has reported Non-Current Deffered Revenue for 12 years, with the latest figure at $4045.0 in Q1 2024.
- Quarterly Non-Current Deffered Revenue changed 0.0% year-over-year to $4045.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $4045.0 (changed 0.0% YoY) and the FY2023 annual result came in at $4045.0, changed 0.0% from the prior year.
- Non-Current Deffered Revenue held at $4045.0 in Q1 2024 per BICX's latest filing, from $4045.0 in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $1.2 million in Q2 2020 and troughed at $4045.0 in Q4 2022.
- A 5-year average of $124545.7 and a median of $19954.0 in 2022 frame the typical range for Non-Current Deffered Revenue.
- The sharpest annual moves came in 2020 and 2022: Non-Current Deffered Revenue soared 584.03% in 2020, then slumped 89.16% in 2022.
- Over 5 years, Non-Current Deffered Revenue stood at $65560.0 in 2020, then slumped by 43.1% to $37301.0 in 2021, then plunged by 89.16% to $4045.0 in 2022, then changed by 0.0% to $4045.0 in 2023, then changed by 0.0% to $4045.0 in 2024.
- According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $4045.0, $4045.0, and $4045.0 for Q1 2024, Q4 2023, and Q3 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn | - |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn | - |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn | - |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | - |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn | - |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn | 98.43 Mn |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn | 146.99 Mn |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn | - |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | - |
| 10 | BioCorRx | 3.46 Mn | 3.44 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 4,045.00 |
| Dec 31, 2023 | 4,045.00 |
| Sep 30, 2023 | 4,045.00 |
| Jun 30, 2023 | 4,045.00 |
| Mar 31, 2023 | 4,045.00 |
| Dec 31, 2022 | 4,045.00 |
| Sep 30, 2022 | 11,137.00 |
| Jun 30, 2022 | 19,954.00 |
| Mar 31, 2022 | 28,675.00 |
| Dec 31, 2021 | 37,301.00 |
| Sep 30, 2021 | 46,118.00 |
| Jun 30, 2021 | 54,935.00 |
| Mar 31, 2021 | 63,656.00 |
| Dec 31, 2020 | 72,281.00 |
| Sep 30, 2020 | 370,023.00 |
| Jun 30, 2020 | 1.15 Mn |
| Mar 31, 2020 | 893,050.00 |
| Dec 31, 2019 | 103,313.00 |
| Sep 30, 2019 | 139,604.00 |
| Jun 30, 2019 | 168,563.00 |